关注
Olga Löblová
Olga Löblová
Department of Sociology, University of Cambridge
在 cam.ac.uk 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
The implementation of managed entry agreements in Central and Eastern Europe: findings and implications
A Ferrario, D Arāja, T Bochenek, T Čatić, D Dankó, M Dimitrova, J Fürst, ...
Pharmacoeconomics 35, 1271-1285, 2017
1622017
Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria
L Gulácsi, AM Rotar, M Niewada, O Löblová, F Rencz, G Petrova, I Boncz, ...
The European journal of health economics 15, 13-25, 2014
1162014
Patients’ perceptions of information and education for renal replacement therapy: an independent survey by the European kidney Patients' Federation on information and support …
W Van Biesen, SN van der Veer, M Murphey, O Loblova, S Davies
PLoS One 9 (7), e103914, 2014
922014
When epistemic communities fail: exploring the mechanism of policy influence
O Löblová
Policy studies journal 46 (1), 160-189, 2018
712018
Centralizing and decentralizing governance in the COVID-19 pandemic: The politics of credit and blame
SL Greer, S Rozenblum, M Falkenbach, O Löblová, H Jarman, N Williams, ...
Health Policy 126 (5), 408-417, 2022
602022
European integration in the era of permissive dissensus: Neofunctionalism and agenda-setting in European health technology assessment and communicable disease control
SL Greer, O Löblová
Comparative European Politics 15, 394-413, 2017
462017
Three worlds of health technology assessment: explaining patterns of diffusion of HTA agencies in Europe
O Löblová
Health Economics, Policy and Law 11 (3), 253-273, 2016
432016
Epistemic communities and experts in health policy-making
O Löblová
European journal of public health 28 (suppl_3), 7-10, 2018
342018
When health technology assessment is confidential and experts have no power: the case of Hungary
M Csanádi, O Löblová, P Ozierański, A Harsányi, Z Kaló, M McKee, ...
Health Economics, Policy and Law 14 (2), 162-181, 2019
312019
Half a century of Wilson & Jungner: reflections on the governance of population screening
S Sturdy, F Miller, S Hogarth, N Armstrong, P Chakraborty, C Cressman, ...
Wellcome Open Research 5, 2020
302020
Rationalizing the introduction and use of pharmaceutical products: The role of managed entry agreements in Central and Eastern European countries
AM Rotar, A Preda, O Löblová, V Benkovic, S Zawodnik, L Gulacsi, ...
Health Policy 122 (3), 230-236, 2018
302018
COVID-19 in Central and Eastern Europe: Focus on Czechia, Hungary, and Bulgaria
O Löblová, J Rone, E Borbáth
Coronavirus Politics: The Comparative Politics and Policy of COVID-19, 2021
272021
The emerging social science literature on health technology assessment: a narrative review
O Löblová, T Trayanov, M Csanádi, P Ozierański
Value in Health 23 (1), 3-9, 2020
262020
What has health technology assessment ever done for us?
O Löblová
Journal of health services research & policy 23 (2), 134-136, 2018
202018
Who’s afraid of institutionalizing health technology assessment (HTA)?: Interests and policy positions on HTA in the Czech Republic
O Löblová
Health Economics, Policy and Law 13 (2), 137-161, 2018
172018
Alternative access schemes for pharmaceuticals in Europe: Towards an emerging typology
O Löblová, M Csanádi, P Ozierański, Z Kaló, L King, M McKee
Health Policy 123 (7), 630-634, 2019
162019
Transparency in practice: evidence from ‘verification analyses’ issued by the Polish Agency for Health Technology Assessment in 2012–2015
P Ozierański, O Löblová, N Nicholls, M Csanádi, Z Kaló, M McKee, L King
Health Economics, Policy and Law 14 (2), 182-204, 2019
162019
Patterns of alternative access: Unpacking the Slovak extraordinary drug reimbursement regime 2012-2016
O Löblová, M Csanádi, P Ozierański, Z Kaló, L King, M McKee
Health Policy 123 (8), 713-720, 2019
142019
The impact of the recession on health care expenditure — How does the Czech Republic, Hungary, Poland and Slovakia compare to other OECD countries?
LG Baji, Petra, Márta Péntek, Imre Boncz, Valentin Brodszky, Olga Loblova ...
Society and Economy 31 (1), 73-88, 2015
10*2015
Is the Polish ‘Law and Justice’(PiS) a Typical Populist Radical Right Party? A Health Policy Perspective
M Zabdyr-Jamróz, O Löblová, AD Moise, I Kowalska-Bobko
The Populist Radical Right and Health: National Policies and Global Trends …, 2021
92021
系统目前无法执行此操作,请稍后再试。
文章 1–20